VIRAL VECTOR & GENE EDITING CORE
Lentiviral Vectors
Overview
What are Lentiviral Vectors?
Lentiviral vectors are powerful tools in basic research and gene therapy, derived from lentiviruses, a subgroup of retroviruses.
Applications in Gene Therapy
Lentiviral vectors have a wide range of applications, including:
- Gene Therapy: They are used to treat genetic disorders by delivering therapeutic cargo to correct defective genes in patients.
- Cancer Treatment: Lentiviral vectors are employed in advanced therapies like CAR Tcell therapy, where T-cells are modified to find and destroy cancer cells.
- Vaccine Development: They are also being explored for use in vaccine development, for diseases where traditional vaccines are ineffective.
- Preclinical Research: Lentiviral vectors are commonly used in basic research to introduce gene products into in vitro systems or animal models, facilitating studies on gene function and regulation.
Advantages of Lentiviral Vectors
- Ability to Infect Non-Dividing Cells: Unlike many other viral vectors, lentiviral vectors can infect both dividing and non-dividing cells, broadening their application
- Stable Gene Expression: Once integrated into the host genome, lentiviral vectors can provide stable and long-term expression of the therapeutic gene.
- Low Immunogenicity: Engineered lentiviral vectors typically exhibit low immunogenicity, reducing the likelihood of an adverse immune response.
Safety Considerations
While lentiviral vectors offer significant therapeutic potential, there are important safety concerns, including:
- Insertional Mutagenesis: The integration of the viral DNA into the host genome can disrupt essential genes or activate oncogenes, potentially leading to cancer.
- Immune Reactions: Although designed to be less immunogenic, there is still a risk of the host immune system recognizing and reacting to the viral components.
Conclusion: Lentiviruses represent a promising avenue in gene therapy and molecular biology, with ongoing research aimed at optimizing their safety and efficacy. Their unique ability to deliver genetic material into a wide variety of cell types makes them invaluable tools in both research and clinical applications.
Product Information
The IPRD Viral Vector and Gene Editing Core offers high-quality lentiviral vectors in multiple grades to support a range of in vitro and in vivo applications. All vector preps are quality-controlled and can be customized upon request.
Titering and Aliquoting
All viral preps are rigorously titered for accuracy and reliability:
- Flow cytometry or antibiotic-resistant colony counts are used for vectors expressing appropriate markers.
- For marker-free vectors, real-time PCR (qPCR) on transduced cells is used.
- Vectors are aliquoted in 1 mL, 10 mL, or 25 µL volumes depending on prep type.
Lentiviral Vector Prep Summary
| Prep Type | Grade | Titer | Total Volume | Aliquot Size | Production Time | New Column | Academic Cost | Non-Academic Cost |
|---|---|---|---|---|---|---|---|---|
| Small Non-concentrated | In Vitro | ≥ 2.5 × 107 vg/mL | 10 mL | 1 mL | 7 days | $300 | $360 | $450 |
| Large Non-concentrated | In Vitro | ≥ 2.5 × 107 vg/mL | 100 mL | 10 µL | 7 days | $750 | $900 | $1,125 |
| Large Concentrated | In Vitro | ≥ 5 × 109 vg/mL | 200 µL | 25 µL | 14 days | $900 | $1,080 | $1,350 |
| Mega Non concentrated | In Vitro | ≥ 2.5 × 107 vg/mL | 1 L | 50 mL | 14 days | $4,000 | $4,800 | $6,000 |
| Small Concentrated | In Vivo | ≥ 5 × 109 vg/mL | 50 µL | 25 µL | 14 days | $900 | $1,080 | $1,350 |
| Medium Concentrated | In Vivo | ≥ 5 × 109 vg/mL | 200 µL | 25 µL | 21 days | $1,462 | $1,792 | $2,231 |
| Large Concentrated | In Vivo | ≥ 5 × 109 vg/mL | 1 mL | 25 µL | 28 days | $6,000 | $7,200 | $9,000 |
How to Order
To connect with the IPRD Viral Vector & Gene Editing Core and place an order, simply email your request to viral.core@med.fsu.edu